DCSIMG

Scottish Business Briefing – Wednesday 18 December

Scotch Whisky Association chief Gavin Hewitt. Picture: TSPL

Scotch Whisky Association chief Gavin Hewitt. Picture: TSPL

WELCOME to scotsman.com’s Scottish Business Briefing. Every morning we bring you a comprehensive round-up of all news affecting business in Scotland today.

MANAGEMENT

Braveheart blames half-year loss on Envestors arm

Investment manager Braveheart today revealed it had fallen into the red during the first half of the year because its former subsidiary Envestors fell victim to poor trading conditions. (Scotsman)

Maven Capital buys £5m R&M stake

MAVEN Capital Partners has bought a controlling stake in the R&M Engineering oil services business from Robbie Mackay in a £5 million deal that shows its faith in the potential of the North Sea market. (Herald)

Read all today’s management news from scotsman.com

FOOD, DRINK & AGRICULTURE

Large hill farms could be winners under new CAP

The first official figures on future area payments likely to be paid to Scottish farmers under the reformed common agricultural policy (CAP) were released yesterday – when the Scottish Government launched its consultation paper on the implementation of Pillar One direct support measures. (Scotsman)

Scotch whisky industry wants alcohol duty escalator scrapped

The Scotch Whisky Association (SWA) has urged the UK government to abolish the automatic annual increase in duty on wines and spirits. (BBC)

(http://www.scotsman.com/business/food-drink-agriculture|Read all today’s food, drink and agriculture news from scotsman.com|Click here}

TRANSPORT & INDUSTRY

Fleet business lifts profits at Ogilvie Group

Ogilvie Group’s accelerating vehicle hire and leasing arm once again drove profits in the last financial year as it continued to benefit from high re-sale prices.

(Scotsman)

Read all today’s transport and industry news from scotsman.com

MEDIA, TECH & LEISURE

Scots drug maker to make cystic fibrosis inhaler

A SPIN-OUT company from the Rowett Institute in Aberdeen has sealed a key deal to develop its cystic fibrosis (CF) medicine to be deliver through an inhaler. (Scotsman)

Read all today’s media. tech and leisure news from scotsman.com

• Sign up to Business Briefing

(The Scotsman Conferences)

 

Comments

 
 

Back to the top of the page

 

EDINBURGH
FESTIVALS
2014

#WOWFEST

In partnership with

Complete coverage of the festivals. Guides. Reviews. Listings. Offers

Let's Go!

No Thanks